Search our Database of Scientific Publications and Authors

I’m looking for a

    Details and Download Full Text PDF:
    Cliques and Schisms of Cancer Genes.

    Cancer Cell 2017 08;32(2):129-130
    Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK; Department of Haematology, University of Cambridge, Cambridge CB2 2XY, UK. Electronic address:
    With a few exceptions, cancers typically carry more than one driver mutation, sometimes five, ten, or more, and these driver mutations do not necessarily assort randomly. In this issue of Cancer Cell, Mina et al. systematically characterize patterns of co-mutation and mutual exclusivity in 6,456 cancers across 23 tumor types.
    PDF Download - Full Text Link
    ( Please be advised that this article is hosted on an external website not affiliated with
    Source Status ListingPossible

    Similar Publications

    BeWith: A Between-Within method to discover relationships between cancer modules via integrated analysis of mutual exclusivity, co-occurrence and functional interactions.
    PLoS Comput Biol 2017 Oct 12;13(10):e1005695. Epub 2017 Oct 12.
    National Center of Biotechnology Information, National Library of Medicine, NIH, Bethesda, MD, United States of America.
    The analysis of the mutational landscape of cancer, including mutual exclusivity and co-occurrence of mutations, has been instrumental in studying the disease. We hypothesized that exploring the interplay between co-occurrence, mutual exclusivity, and functional interactions between genes will further improve our understanding of the disease and help to uncover new relations between cancer driving genes and pathways. To this end, we designed a general framework, BeWith, for identifying modules with different combinations of mutation and interaction patterns. Read More
    Detection of driver pathways using mutated gene network in cancer.
    Mol Biosyst 2016 06;12(7):2135-41
    School of Computer Science and Technology, Xidian University, Taibai South Road 2#, Xi'an, Shaanxi Province 710071, P. R. China.
    Distinguishing driver pathways has been extensively studied because they are critical for understanding the development and molecular mechanisms of cancers. Most existing methods for driver pathways are based on high coverage as well as high mutual exclusivity, with the underlying assumption that mutations are exclusive. However, in many cases, mutated driver genes in the same pathways are not strictly mutually exclusive. Read More
    Dynamic changes of driver genes' mutations across clinical stages in nine cancer types.
    Cancer Med 2016 Jul 19;5(7):1556-65. Epub 2016 Mar 19.
    Laboratory for Gene and Cell Engineering, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, 1068 Xueyuan Avenue, Shenzhen University Town, Shenzhen, China.
    The driver genes play critical roles for tumorigenesis, and the number of identified driver genes reached plateau. But how they act during different cancer development stages is lack of knowledge. We investigated 138 driver genes' mutation changes across clinical stages using 3,477 cases in nine cancer types from the Cancer Genome Atlas (TCGA) and constructed their temporal order relationships. Read More
    De novo discovery of mutated driver pathways in cancer.
    Genome Res 2012 Feb 7;22(2):375-85. Epub 2011 Jun 7.
    Department of Computer Science and Center for Computational Molecular Biology, Brown University, Providence, Rhode Island 02912, USA.
    Next-generation DNA sequencing technologies are enabling genome-wide measurements of somatic mutations in large numbers of cancer patients. A major challenge in the interpretation of these data is to distinguish functional "driver mutations" important for cancer development from random "passenger mutations." A common approach for identifying driver mutations is to find genes that are mutated at significant frequency in a large cohort of cancer genomes. Read More